Paul Y. Goldberg

Affiliations

  • Svp, Clinical Development at Xenon Pharmaceuticals Inc. (XENE), 2017-10-24
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
XENE $8.60 12,000 Officer 6,000 2015-09-24 Filing
XENE $9.02 4,000 Officer 18,000 2015-09-23 Filing
XENE $9.33 6,149 Officer 22,000 2015-09-22 Filing